Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: WeirdPro Randy who wrote (584)	3/6/1998 7:16:00 PM
From: limit	Read Replies (1) \| Respond to of 998

Thanks for the update. This is where the GOLD is!

To: WeirdPro Randy who wrote (584)	3/13/1998 3:09:00 PM
From: Rudy Saucillo	Read Replies (1) \| Respond to of 998

This is great news, WeirdPro! I attended both of the previous Myo panels and can say that the AC members were not unsympathetic with the patients' efforts. The T-IND data to be reviewed is exactly what the AC expected previously. I believe that (1) if CEPH presents the data without any statistical tricks, and (2) if the data is in the least bit positive, we'll see an approval recommendation followed quickly by FDA approval. At this point I believe it's a coin toss given the data previously presented, but I'm hopeful. Cheers! Rudy